Select Medical Stock Price, News & Analysis

Select Medical Holdings Corporation (NYSE: SEM) will release its third quarter 2025 financial results for the period ended September 30, 2025 on Thursday, October 30, 2025 after market close. Management will host a conference call and live webcast on Friday, October 31, 2025 at 9:00 AM ET to discuss results and business outlook. A replay will be available shortly after via the same webcast link on the company's website. Investor dial-in access requires pre-registration to obtain a dial-in number and passcode.

As of June 30, 2025, Select Medical operated 104 critical illness recovery hospitals, 36 rehabilitation hospitals, and 1,919 outpatient rehabilitation clinics across 40 states and the District of Columbia.

Select Medical Holdings (NYSE: SEM) has announced significant leadership changes, appointing Thomas P. Mullin as its new Chief Executive Officer. Mullin, a 17-year company veteran, previously served as co-president overseeing 140 critical illness recovery and inpatient rehabilitation hospitals.

In concurrent moves, former CEO David S. Chernow has been appointed vice chairman of the board, John A. Saich becomes sole president, and John F. Duggan takes on the role of executive vice president, general counsel and secretary. Additionally, Michael E. Tarvin transitions to senior executive vice president of legal services.

These appointments represent an internal succession plan, with all appointees being long-term company veterans with extensive experience in various leadership roles within Select Medical.

Select Medical Holdings (NYSE:SEM) reported strong Q2 2025 financial results, with revenue increasing 4.5% to $1.34 billion. The company's income from continuing operations, net of tax, surged 53.8% to $57.9 million, while earnings per share jumped 88.2% to $0.32.

The company operates through three main segments: 104 critical illness recovery hospitals, 36 rehabilitation hospitals, and 1,919 outpatient rehabilitation clinics. While the rehabilitation hospital segment showed strong growth with a 17.2% revenue increase, the critical illness recovery segment experienced some pressure with declining margins.

Select Medical declared a cash dividend of $0.0625 per share and continued its stock repurchase program, having bought back 6.37 million shares for $96.5 million in H1 2025. The company reaffirmed its 2025 outlook with expected revenue of $5.3-5.5 billion and Adjusted EBITDA of $510-530 million.

Select Medical Holdings Corporation (NYSE: SEM), a leading operator of healthcare facilities in the United States, has scheduled its Q2 2025 earnings release for Thursday, July 31, 2025 after market close. The company will host a conference call to discuss results and business outlook on Friday, August 1, 2025, at 9:00am ET.

Select Medical operates 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,911 outpatient rehabilitation clinics across 39 states and the District of Columbia, making it one of the largest healthcare facility operators in the country.

Select Medical (NYSE:SEM) has announced a strategic partnership with Ballad Health to jointly operate Select Specialty Hospital – Tri-Cities, a 46-bed critical illness recovery hospital in Kingsport, Tennessee. The facility will relocate from Ballad Health's Bristol Regional Medical Center to Indian Path Community Hospital as a hospital-in-hospital arrangement.

Select Medical will serve as the majority owner and managing partner of the joint venture. The company has been serving the region's post-ICU care needs for over 25 years and operates six additional critical illness recovery hospitals throughout Tennessee. The relocation and partnership aim to expand access to specialized post-acute care services in the region.

Select Medical Holdings (NYSE: SEM) reported its Q1 2025 financial results with revenue increasing 2.4% to $1.35 billion. The company's income from continuing operations, net of tax, rose 21.5% to $74.7 million, while earnings per share increased 33.3% to $0.44. However, Adjusted EBITDA decreased to $151.4 million from $165.8 million year-over-year. The rehabilitation hospital segment showed strong performance with a 15.7% revenue increase to $307.4 million. The company declared a cash dividend of $0.0625 per share and continued its stock repurchase program, buying back 649,804 shares at approximately $11.4 million. Select Medical adjusted its 2025 outlook, expecting revenue between $5.3-5.5 billion and Adjusted EBITDA of $510-530 million.

Select Medical Holdings (NYSE: SEM) has scheduled its first quarter 2025 financial results announcement for Thursday, May 1, 2025, after market close. The company will host a conference call and live webcast to discuss the results and business outlook on Friday, May 2, 2025, at 9:00am ET.

As of March 31, 2025, Select Medical operates a substantial healthcare facility network including 104 critical illness recovery hospitals across 29 states, 35 rehabilitation hospitals in 14 states, and 1,911 outpatient rehabilitation clinics in 39 states and the District of Columbia. The company's operations span 41 states and D.C., making it one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.

Select Medical Holdings (NYSE: SEM) announced its Q4 and full-year 2024 results, along with its 2025 outlook and dividend declaration. Key highlights include:

The company completed a tax-free distribution of Concentra shares on November 25, 2024. Q4 2024 revenue increased 7.8% to $1,312.6 million, though the company reported a loss from continuing operations of $10.5 million, impacted by a one-time $45.9 million stock compensation expense and $17.9 million debt refinancing loss.

For full-year 2024, revenue grew 7.5% to $5,187.1 million, with income from continuing operations increasing 17.7% to $130.0 million. The board declared a cash dividend of $0.0625 per share, payable March 13, 2025. The company also maintains a $1.0 billion stock repurchase program through December 31, 2025.

The 2025 business outlook projects revenue between $5.4-5.6 billion and Adjusted EBITDA of $520.0-540.0 million.

Select Medical Holdings (NYSE: SEM) has scheduled its fourth quarter and full year 2024 financial results release for Thursday, February 20, 2025, after market close. The company will host a conference call to discuss results and business outlook on Friday, February 21, 2025, at 9:00am ET.

As of December 31, 2024, Select Medical operates 104 critical illness recovery hospitals in 29 states, 35 rehabilitation hospitals in 14 states, and 1,914 outpatient rehabilitation clinics across 39 states and the District of Columbia. The company's operations span 41 states and D.C., making it one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.